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ABSTRACT SpGCF1 is a recently cloned sea urchin
transcription factor that recognizes target sites in several
different sea urchin genes. We find that in gel-shift experi-
ments this factor is able to multimerize. A quantitative
simulation of the gel-shift results suggests that SpGCF1
molecules that are bound to DNA target sites may also bind to
one another, thus associating several DNA probe molecules.
SpGCF1 might therefore be able to loop DNA molecules
bearing its target sites at distant locations. We demonstrate
this prediction by electron microscopy, and using the well-
characterized cis-regulatory domain of the CyllIa cytoskeletal
actin gene, we show that the loop conformations predicted
from the known SpGCF1 target site locations are actually
formed in vitro. We speculate that the multimerization of this
factor in vivo may function to bring distant regions ofextended
regulatory domains into immediate proximity so that they can
interact with one another.
SpGCF1 is a sea urchin embryo transcription factor that binds
tightly to certain target site sequences surrounding a core
CCCCN sequence, where N is usually T. Most of our knowl-
edge of the function of this protein in vivo derives from studies
on the Strongylocentrotus purpuratus CyIIIa cytoskeletal actin
gene, which is expressed exclusively in the aboral ectoderm of
the embryo and larva. As shown in Fig. 1, the distal end of this
regulatory domain (5-8) includes a cluster of SpGCF1 sites
(cluster A). If these sites are deleted from a transgene con-
struct consisting of the 5' leader and upstream sequences of
CyIIIa ligated to the bacterial chloramphenicol acetyltrans-
ferase (CAT) gene (9), expression of the CyIIIa-CAT trans-
gene is sharply reduced. The same result is obtained if the
factor is sequestered away from the CyIIIa-CAT fusion gene by
cointroduction of excess target sites-i.e., in vivo competition
(10, 11)-though this does not affect the spatial domain of the
remaining expression. Similar in vivo competition results were
obtained with the SpGCF1 sites of region E of the CyIIIa
regulatory domain (Fig. 1; refs. 10 and 11). In the CyIIIa gene,
these sites mediate a positive transcriptional activation func-
tion. A protein binding specifically to these sites, called
SpGCF1, was purified from embryo nuclear extracts and
cloned by Zeller et al. (12), though it remains possible that
other proteins recognizing these sites could also be present in
the nuclei. Although in sequence SpGCF1 resembles no other
known protein, a specific DNA-binding domain has been
identified experimentally. The N-terminal region of SpGCF1
contains a high concentration of proline residues, a feature
associated with a transcriptional activation function in some
other known transcription factors (12-15). A particularly
interesting characteristic of SpGCF1 is that it is present in five
different forms, with molecular masses of 37, 40, 43, 50, and 55
kDa. These forms differ in that they include increasing extents
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FIG. 1. Locations of SpGCF1 binding sites in the 2.3-kb CyIIIa
regulatory domain. Binding sites for SpGCF1 protein (from unpub-
lished data and refs. 1-3) are shown as filled ovals. Open boxes indicate
the positions of other DNA-binding protein target sites: 1, P1 site; 2,
SpOctl site (4); 3, SpP3A site; 4, SpTEF1 site; 5, SpCTF1 site; 6, the
pair of SpZ12-1 sites (5); 7, SpP7II site; 8, Spruntl site; and 9, newly
discovered site designated the P9 site. The arrow indicates the start of
transcription. The regulatory region displayed here extends from
-2160 to + 131. The percentage values indicate the distance from the
various SpGCF1 sites to the ends of the DNA molecule.
of the N-terminal proline-rich domain (12). All five forms are
translated from the same mRNA by alternative utilization of
one of five in-frame ATG codons (12).
For some time we have been puzzled by the prevalence and
distribution of SpGCF1 target sites in the cis-regulatory do-
main of both CyIIIa and another gene that we have been
interested in, the Endol6 gene. Endol6 is expressed in the
vegetal plate and archenteron of the embryo (16, 17). The
-2500-bp cis-regulatory domain of Endol6 contains >20
distinct sites where SpGCF1 binds specifically. As in CyIIIa
(Fig. 1) these sites usually occur in clusters and often lie close
to sites where other transcription factors bind. SpGCF1 sites
also appear in the regulatory domain of SM30, a skeletogenic
gene (18). Thus, this factor appears to interact with target sites
in genes expressed in at least three different embryonic
territories, namely aboral ectoderm, vegetal plate, and skel-
etogenic territories. We measured the relative equilibrium
constants for the interactions of SpGCF1 with three of its
CyIIIa target sites and found (1, 12) that the preference of this
protein for these particular sites [with reference to
poly(dA-dT)] ranges from 5 x 104 to 106. SpGCF1 is
therefore a DNA-binding protein which recognizes its target
sites with high specificity. In this communication we describe
a new functional characteristic of SpGCF1, namely its ability
to multimerize with itself. Perhaps this feature explains both
the distribution and prevalence of SpGCF1 sites: interactions
between bound SpGCF1 molecules might have the function of
bringing into immediate proximity other transcription factors
bound at distant locations within the regulatory domain so that
these factors are able to form functional complexes with one
another. This would imply that the DNA sequence between
interacting SpGCF1 molecules can be looped out. Though we
have no evidence for such conformations in vivo, we show that
the expected DNA loops indeed form in a purified system in
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which the only macromolecular components are recombinant
SpGCF1 and the CyIIIa regulatory DNA sequence repre-
sented in Fig. 1.
MATERIALS AND METHODS
Protein Production and Gel Mobility-Shift Assays. Recom-
binant SpGCF1 protein was expressed in Escherichia coli and
renatured as described (12). Gel mobility-shift assays were
performed essentially as described (1). The target-site probe
used in the gel mobility shifts was a 44-bp fragment of the
CyIIIa regulatory DNA located between -2027 and - 1983 in
the sequence (2). It was labeled by the end-fill reaction (1).
The concentration of active SpGCF1, determined by excess
probe titration (1, 12) to be 5.8 nM, was divided among the five
mass variants. This represents about 1% of the total recom-
binant SpGCF1 in the preparation. Aliquots (4 gl) containing
various amounts of the protein were dispensed into tubes on
ice. To each of these tubes was added 16 ,ul of a premixed
solution of the probe (15-50 pM) and lx binding buffer [83
mM KCl/5 mM MgCl2/20 ,uM EDTA/700 ,uM dithiothrei-
tol/14 mM Hepes-KOH, pH 7.9/2% (vol/vol) glycerol]. The
complexes were allowed to form on ice for 10-15 min, and
were then loaded directly onto an 8% polyacrylamide gel
(30:0.8 acrylamide:bisacrylamide) previously prerun for an
hour. After electrophoresis at 250 V, the gel was dried,
exposed to a Kodak imaging screen, and subsequently analyzed
in a Molecular Dynamics Phosphorlmager. Data were con-
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verted to cpm by reference to a known probe sample that was
counted in both the scintillation counter and the Phosphorlm-
ager.
Electron Microscopy of DNA-Protein Complexes. Samples
were prepared for EM by incubating 1 ng of the 2.3-kb CyIIIa
regulatory region-i.e., positions -2160 to + 131-with
SpGCF1 protein for 10 min on ice in 1 x binding buffer (final
volume, 25 ,ul; final protein concentration, 1.75 nM). Follow-
ing incubation, the sample was treated with 0.6% glutaralde-
hyde for 15 min on ice, then chromatographed over 2 ml
Bio-Gel A-Sm (Bio-Rad) columns equilibrated in 10 mM Tris-
HCl/0.1 mM EDTA, pH 7.5. The peak fraction containing the
DNA-protein complexes was treated as described (19). In
brief, thin carbon foils supported by 400-mesh copper grids
were exposed to a glow discharge, and the complexes were
adsorbed for 30 sec in a buffer containing 2 mM spermidine
and 150 mM NaCl. The grids were then rinsed with sequential
washes of water and a graded series of ethanol solutions up to
100% ethanol. The samples were air dried and rotary shad-
owcast with tungsten at 10-7 torr (1 torr = 133.3 Pa).
Images were recorded on sheet or 35-mm film by using a
Philips CM12 electron microscope. Images for analysis or
publication were captured from the film by using a Cohu CCD
camera and a Data Translation Quick Capture board in a
Macintosh computer. The NIH IMAGE software was used to
adjust the contrast in the images for publication. Images were
transferred to 35-mm film by using a GCC (San Jose, CA) film
recorder. Lengths ofDNA segments on the micrographs were
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FIG. 2. Quantitative protein excess gel-mobility assay. (A) Phosphorlmager report of the labeled complexes formed. A synthetic DNA probe
bearing a single SpGCF1 target site was incubated with increasing amounts of recombinant SpGCF1 protein. The complexes formed were resolved
by electrophoresis through an 8% polyacrylamide gel. The amount of added protein increases from left (lane 1, 1.8 x 10-11 M) to right (lane 11,
5.8 x 10-10 M). Bands 1-5 (denoted on the right) indicate the complexes formed by the different SpGCF1 variants binding to the probe (see text).
Region 5-A and bands A and B are complexes formed by SpGCF1/SpGCF1 interactions, as described in text. FP, free probe. (B) Curves generated
by the dimer model for SpGCF1 complex formation discussed in text and in Appendix. The solid lines show the functions generated by using the
least squares solution for the parameters of the model for these data. Each panel represents one of the bands figured in A, as indicated. The data
from the Phosphorlmager analysis are indicated as open symbols after normalization, so that the probe present in each complex is expressed as
a fraction of total probe in the experiment. D represents free probe.
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measured on the photographic prints by using a Summagraph-
ics (Fairfield, CT) digitizing tablet coupled to a CompuAdd
computer programmed with software developed in the labo-
ratory of J.D.G.
RESULTS
Multimerization of SpGCF1 on a Single-Site Probe. An
example of a gel-shift experiment that reveals the multimer-
ization of SpGCF1 is shown in Fig. 2A. Increasing amounts of
renatured recombinant SpGCF1 were mixed with a 44-nt
oligonucleotide probe (see Materials and Methods) that con-
tained a single target binding site. The bands formed at the
lower protein concentrations (bands 1-5; Fig. 2A, lanes 1-7)
represent complexes formed, respectively, by the 37-, 40- 43-,
50-, and 55-kDa variants of the protein. This was shown earlier
(12) by the use of two-dimensional gel electrophoresis and
immunological identification of the complexes with a poly-
clonal antibody that recognizes the C-terminal region of the
protein that is common to all five variants. As protein con-
centration is increased, more slowly migrating complexes
appear. A blurred region of the gel is seen above the band
containing the complex with the 55-kDa variant in lanes 8-11
(region 5-A), representing a series of complexes that are too
close to one another in size to be resolved into discrete bands.
Above this region, two more sharply resolved sets of complexes
(bands A and B in Fig. 2A) appear at the highest protein
concentrations. Since there is only a single target site on the
probe, and since no proteins other than the purified recom-
binant SpGCF1 are present in the experiment, all the com-
plexes migrating more slowly than that formed by the 55-kDa
variant must be due to SpGCF1/SpGCF1 interactions that
involve SpGCF1 molecules that are also bound to the labeled
DNA probe. The same set of slowly migrating complexes
appears at high protein levels when natural SpGCF1 concen-
trated from nuclear extract by affinity chromatography is
reacted with a CyIIIa probe (data not shown). Therefore, the
slowly migrating complexes illustrated in Fig. 2A are not due
to nonrenatured recombinant SpGCF1 that cannot bind DNA,
which is present in large amounts in the protein preparations
we used for this experiment.
In order to interpret the results of experiments such as
shown in Fig. 2A, we constructed models of the presumed
interactions based on simple equilibrium considerations (see
Appendix). These models allowed us to test a number of
different stoichiometries. The best fits to the data were
obtained with what we termed the dimer model and are shown
in Fig. 2B. The assumptions on which this model is based and
the number of SpGCF1 molecules and DNA probe molecules
assumed in this model for each of the complexes observed are
detailed in Appendix. Very briefly, the compositions of the
individual bands in the dimer model are as follows: Bands 1-5
are formed of homodimers of the SpGCF1 size variants
complexed to a single DNA probe molecule-i.e., the 37-kDa
variant dimerizes only with another 37-kDa variant, the 55-
kDa variant dimerizes only with itself, and so forth. The
steepness with which these complexes accumulate with in-
creasing protein concentration excludes monomeric com-
plexes. (Cooperativity in DNA binding is not an issue since
there is only a single target site per probe.) Band 5-A in the
dimer model consists of unresolved complexes formed be-
tween monomers of any of the SpGCF1 variants and any of the
DNA/(SpGCF1)2 complexes represented in bands 1-5. Region
5-A complexes result from SpGCF1/SpGCF1 interactions that
occur at higher protein concentrations than does formation of
the initial complexes with DNA. Band A in this model consists
of dimers of the (SpGCF1)3/DNA complexes represented in
Region 5-A-i.e., band A complexes contain six SpGCF1
molecules and two DNA molecules per complex. Band B
consists of dimers of the complexes formed in band A-i.e.,
band B complexes consist of twelve SpGCF1 molecules and
four DNA probe molecules per complex. Thus both band A
and band B consist of complexes in which DNA probe
molecules already complexed to SpGCF1 dimers are brought
into a higher order multimeric complex by further SpGCF1/
SpGCF1 interactions.
SpGCF1 Loops DNA That Contains Multiple Target Sites.
If SpGCF1 molecules already bound to their DNA target sites
are capable of binding specifically to one another, as in the
interpretation of Fig. 2A just discussed, then such interactions
should occur between SpGCF1 molecules bound at target sites
at distant locations on the same DNA molecule. This would
result in the formation of a DNA loop held together by
SpGCF1 complexes that could be visualized by EM (20-22).
We utilized the 2.3-kb CyIIIa regulatory domain DNA frag-
ment illustrated in Fig. 1 for a direct test of this prediction and
a 600-nt control fragment that included only the "E" SpGCF1
cluster of target sites. The latter should display protein-DNA
complexes but no loops, and this is indeed what was observed
(data not shown). However, when mixed with SpGCF1 pro-
tein, the 2.3-kb CyIIIa regulatory DNA fragment formed loops
at a frequency of over 60% (see Materials and Methods for
conditions).
To analyze these loop structures the distances between the
ends of the DNA molecules and the bound SpGCF1 protein at
the base of the loop(s) were measured. As Fig. 1 indicates, the
SpGCF1 target sites and site clusters are located in such a
fashion that the loops which could be formed by interactions
at any two of these sites will produce ends of different lengths
that can be identified unambiguously. Table 1 records the
different forms of loops that are thus recognized, and cate-
gorizes them according to the site nomenclature of Fig. 1.
Table 1 includes data from 59 loop structures that were clearly
visualized and that we examined in detail. Examples of many
of these categories of loop structure that we saw are shown in
Fig. 3. As indicated in Table 1, most of the possible binary
interactions that could occur were in fact included in the
sample of 59 structures analyzed. The frequency of given loops
as opposed to others reflects the relative magnitude of the
equilibrium constants for the target sites at which they form,
at least in those cases for which we have data. For example,
Table 1. Categories of loops in sample of 59 structures
No. of loops
per molecule
1 (71.2%)
2 (22.0%)
3 (5.1%)
5 (1.7%)
Total
No. of
Interaction(s) occurrences
AA
AB
AC
AD
AE
BC
BD
BE
CD
CE
DE
AAC
ABC
ACD
ACE
BCD
BCE
CDE
AABD
ABCD
ABCF
AACDEE
2
4
9
9
3
5
0
1
4
2
3
2
1
2
3
3
1
1
1
1
1
1
59
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containing SpGCF1 target sites was incubated with purified SpGCF1
protein and prepared for EM by directly mounting onto thin carbon
foils, air drying, and rotary shadowcasting with tungsten. The sites
where the SpGCF1 molecules whose interactions form the loops are
bound are indicated in each panel. Images are shown in reverse
contrast. (Bar' = 0.2 pkm.)
some sites in region A have an apparent equilibrium constant
for SpGCF1 interaction that is about 10 times higher than for
the other measured CylIIa sites, probably because of the
opportunity for cooperative interactions between adjacent,
bound SpGCF1 molecules within this cluster. Correspond-
ingly, a major fraction of all the loops observed involved site
cluster A (49 of the 59 structures analyzed; Table 1). Single
loops formed by SpGCF1 interactions at two sites, as illus-
trated in Fig. 3 A-E, accounted for 71% of the structures we
studied (42 of the 59 structures), and multiple loop structures
accounted for the remainder. For example, Fig. 3F and G show
double loops formed by triple interacti'ons and Fig. 3H shows
a five-loop structure formed by interactions at six possible
sites.
DISCUSSION
The correlation between the positions of SpGCF1 target sites
in the CyIIIa regulatory domain and the positions of loop-
forming sites, together with the high frequency of looped
structures that we encountered in these experiments, confirms
that SpGCF1 bound to DNA is capable of forming stable
Proc. Natl. Acad Sci USA 92 (1995)
multimeric complexes. In the gel-shift experiment of Fig. 2A,
this property evidently results in the sequestration of several
DNA probe molecules per complex (bands A and B), and in
the electron microscope study, it results in the formation of
DNA loops. This conclusion stands independently of the exact
stoichiometry of the complexes formed in the gel-shift exper-
iment, which will require direct protein cross-linking to estab-
lish.
SpGCF1 evidently behaves very much like the mammalian
Spl transcription factor. Spl is a transcriptional activator that
binds G+C-rich target sites, which often appear in clusters (23,
24). Just like SpGCF1, Spl also forms higher multimeric
complexes' when bound to DNA probes, as visualized in
gel-shift experiments (25). Furthermore, two different groups
(21, 22) have shown by EM that in vitro, Spl loops DNA
bearing multiple binding sites in the same way as does
SpGCF1. However, SpGCF1 is not a sea urchin version of Spl,
since SpGCF1 has an entirely dissimilar sequence from Spl. In
fact, SpGCF1 displays no sequence similarity with any other
known transcription factor (or other protein) (12). Thus, two
completely unrelated transcription factors share the specific
property of looping DNA by the formation in vitro of stable
multimers between transcription factor molecules bound to
DNA at distant sites. It follows that this property might reflect
an important in vivo function.
The following is a speculation on the nature of this function
that is suggested by the distribution of SpGCF1 sites in the
CyIIIa regulatory domain. As indicated in Fig. 1, the A-B
SpGCF1 site cluster lies at the distal end of the regulatory
domain; the C-site cluster occurs toward the middle of the
sequence where the SpGCF1 sites are contiguous to sites for
two other transcription factors (labeled 7 and 8 in Fig. 1); the
proximally located D and E sites bracket target sites for four
additional transcription factors (labeled 1-4 in Fig. 1). Earlier
work (5, 10, 11) and extensive gene transfer studies to be
reported elsewhere show that these three regions of the CyIIIa
regulatory domain have distinct functions. The distal region,
which consists mainly of the SpGCF1 target sites of the A-B
cluster, controls the level of expression mediated by the
proximal and middle modules of the regulatory domain and
has no spatial control function of its own. The proximal and
middle modules each include target sites for'both negatively
and positively acting transcription factors, and they each
exercise control over the spatial patterns of CyIIIa expression.
The proximal module alone (target sites 1-5 plus SpGCF1 sites
D and E in Fig. 1) suffices to set expression in the aboral
ectoderm early in development. The middle module (target
sites 6-8 plus SpGCF1 site C in Fig. 1) controls spatial and
temporal patterns of expression in postgastrular embryos, but
it requires portions of the proximal module for function. All
three of these components of the regulatory domain are
required for normal embryonic expression of CyIIIa trans-
genes, and they obviously must intercommunicate in some way;
early in development distal-proximal intercommunication is
required and later on distal-middle-proximal intercommuni-
cation is required. Formation of stable multimeric complexes
between SpGCF1 molecules bound at the distal, middle, and
proximal target sites could provide the specific mechanism for
the physical- intercommunication of transcription factors
bound within individual regulatory modules with one another
and with the basal transcription apparatus that will be located
immediately adjacent to the proximal regulatory module.
Thus, early in development we imagine a distal-proximal DNA
loop (compare Fig. 3D) that would bring the activation func-
tion of distal SpGCF1 modules into direct proximity of the
basal apparatus and the proximal transcription factors. Later
in development multimerization of SpGCF1 bound at the A-B
sites with SpGCF1 bound at the C and D and E sites would be
predicted (compare Fig. 3 G and H). Similar arguments could
apply to the Endol6 gene regulatory system mentioned in the
Proc. Natl. Acad Sci USA 92 (1995) 2993
Introduction, where SpGCF1 sites are again associated with
cis-regulatory modules distributed over more than 2 kb of
DNA. Thus, in general terms our speculation is that SpGCF1
carries out the essential function of a regulatory module
intercommunicator, as well as serving as a transcriptional
activator in its own right. The multimerization and DNA
looping behavior of this protein that we observe in vitro would
reflect this ubiquitously required in vivo function, and we
propose that this function explains the widespread prevalence
and local distribution of SpGCF1 sites in the cis-regulatory
domains of sea urchin genes.
APPENDIX
The accumulation of probe in the specific complexes shown in
Fig. 2A as a function of protein concentration was tested
against several models that might explain the formation and
composition of these complexes. We compared the functions
generated from these models to the data obtained from
scanning the gels by Phosphorlmager by means of a nonlinear
least-squares procedure. The concentrations of recombinant
SpGCF1 protein and of oligonucleotide probe were known a
priori, as were the fractions of total protein (4) for each of the
SpGCF1 molecular weight variants: where i or j denotes the
37-, 40-, 43-, 50-, and 55-kDa variants, and P is protein, Pi =
O)P; 10i = 1. We also knew (3, 12) that bands 1-5 contain only
the 37-, 40-, 43-, 50-, and 55-kDa variants, respectively-i.e., if
these complexes contain multimers of SpGCF1 protein they
are homomultimers and not heteromultimers. Three models,
and the degree to which they conformed to the data, expressed
as x2 values (o = 10%, N = 13 x 8; 11 x 8 for the two data
sets), are shown in the following Table. Here, where n is the
number of SpGCF1 (P) molecules, and m is the number of
DNA (D) probe molecules per complex, we have used the
convention n.m to describe the composition of the complexes:
Model Band
"Monomer" 1-5
Region 5-A
A
B
"Dimer" 1-5
Region 5-A
A
B
"Tetramer" 1-5
Region 5-A
A
B
n.m; composition
x2 (two
data sets)
1.1; PiD
2.1; Pj/PiD I811.4.2; (Pj/PiD)2 18.1, 15.0
8.4; ((Pj/PiD)2)2
2.1; (Pi)2D
3.1; Pj/Pi)2D 5I 3 3.8
6.2; (Pj/(Pi)2D)2 ., .
12.4; ((Pj/(Pi)2D)2)2
4.1; (Pi)4D
5.1; Pj/(Pi)4D 9I
,1.
10.2; (Pj/(Pi)4D)2 9.6, 10.2
12.4; ((Pj/(Pi)4D)2)2
In constructing these models we assumed that all the mass
variants of SpGCF1 may not interact with DNA with exactly
the same equilibrium constant (kN); kNi = p1kN [pi values were
known from earlier experiments (12)]. The equilibrium con-
stant for SpGCF1/SpGCF1 interaction is kE; for the interaction
(Pj/(Pi)2D)/(Pj(Pi)2D) it is kD; for the interaction (Pj/
(Pi)2D)2/(Pj/(Pi)2D)2 it is k. Where Si = p14)12, and S = SS,
the equations used to describe the complexes formed in the
dimer model are: bands 1-5, PD2.1 = SikN-P2-D; Region 5-A,
PD3.1 = kE-SkNP3D; band A, PD6.2 = kD-kE2S2-kN2P6D2; and
band B, PD12.4 = kQ kD2 kE4-S4 kN4 P12 D4. It is worth noting
also that in this model bands 1-5 approximately display an
expected log-linear relation between mass and mobility in the
gel, but this is no longer so for the higher order complexes.
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